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Introduction: Symptomatic cardiac involvement is seen in less than 5% of all cases of sarcoidosis. Although
clinically apparent cardiac sarcoidosis is an uncommon entity, ventricular tachyarrhythmias as the first presenting
symptom are very rare.
Case presentation: We discuss the case of a 41-year-old Asian woman who presented to our hospital with
intermittent palpitation and on evaluation was diagnosed to have systemic sarcoidosis with cardiac involvement.
She was started on multiple antiarrhythmic drugs and corticosteroids without any satisfactory response.
Conclusions: Our case report indicates that sarcoidosis can manifest as ventricular tachycardia without any
detectable systemic findings. This makes sarcoidosis an important diagnostic consideration in patients with
ventricular tachycardia of unknown origin given the high mortality associated with ventricular tachyarrhythmias.
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Sarcoidosis is a multisystem granulomatous disorder of
unknown etiology that mainly affects the lungs, skin, eyes,
and lymphoreticular system, with cardiac involvement
being a rare entity. A recent review of sarcoidosis placed
cardiac involvement at 2%; it is one of the least common
manifestations [1]. However, cardiac involvement may be
an asymptomatic accompaniment to pulmonary disease or
may be the presenting features of systemic sarcoidosis.
Cardiac involvement with sarcoidosis is found at autopsy
in approximately 25% of patients with the disease; how-
ever, only 2 to 5% of all patients with sarcoidosis have
clinically significant cardiac symptoms such as congestive
heart failure, heart block, ventricular arrhythmia, or sud-
den death [2].
Although the disease can manifest itself with compara-
tively benign signs and symptoms, cardiac involvement can
prove to be fatal [3]. The early identification and prompt
treatment of cardiac sarcoidosis can reduce the chances of
sudden cardiac death [4]. Here we present the rare case of
a patient who had no history of systemic sarcoidosis before
she presented with refractory monomorphic ventricular* Correspondence: drsanjeevsinha2002@yahoo.com
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reproduction in any medium, provided the ortachycardia (VT) with a fatal outcome. In our case report
we would like to draw attention to the importance of
ruling out cardiac involvement in any cases with systemic
sarcoidosis to prevent unfavorable outcomes.
Case presentation
A 41-year-old Indian woman presented with a history of
intermittent palpitations of 10 days’ duration to our hos-
pital. She denied any history of fever, cough, chest pain,
dyspnea or syncope or relevant past history of these. She
had a past history of pulmonary tuberculosis in 1992 with
6 months of antitubercular treatment. She denied any past
history of hypertension, coronary artery disease, diabetes
mellitus, thyroid or connective tissue diseases. On exam-
ination she was afebrile with a regular pulse of 142 beats/
minute, and a blood pressure of 120/70mmHg. She had
brownish, waxy papules in the skin of her bilateral lower
limbs above her medial malleolus but the rest of the gen-
eral physical examination did not reveal any abnormal
findings. Her systemic examination was within normal
limits. She was transferred from our emergency depart-
ment to the cardiac coronary unit and a synchronized
electrical cardioversion successfully terminated her VT.
On investigation, her hemogram, blood biochemistry,
liver, renal function and thyroid function were within
normal limits. Her angiotensin-converting enzyme leveld. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 High-resolution computed tomography scan of the
chest showing peribronchial and subpleural nodules, interstitial
thickening and bilateral hilar lymphadenopathy.
Figure 3 Evidence of active disease in bilateral lungs and
mediastinum shown on 18F-fluorodeoxyglucose positron
emission tomography scans.
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was normal. Her immunological markers were negative
with normal erythrocyte sedimentation rate and C-reactive
protein. A contrast-enhanced computed tomography (CT)
chest scan showed findings suggestive of stage-III sarcoi-
dosis (Figure 1). A slit lamp examination of her eyes did
not reveal any abnormal findings. An electrocardiogram
showed monomorphic VT and right bundle branch block
with right axis deviation (Figure 2).
To evaluate the extent of the disease an 18F-
fluorodeoxyglucose positron emission tomography-
computed tomography (PET)-CT scan was performed.
The study showed evidence of active disease involving
her bilateral lungs, mediastinal, right supraclavicular,
peripancreatic and retrocrural lymph nodes with focal
lesions in segments VII and VIII of her liver (Figure 3).
As the supraclavicular node was not palpable, a biopsy
was attempted from the superficial lesion in the right
lobe of her liver. This biopsy showed interstitial fibrosis
but no evidence of epithelioid granulomas. A skin bi-
opsy from a waxy papule of her lower limb showed
non-caseating epithelioid cell granuloma suspicious for
sarcoidosis (Figure 4). A Ziehl–Neelsen stain showedFigure 2 Electrocardiogram showing monomorphic ventricular tachycan absence of acid-fast bacilli. A diagnosis of systemic
sarcoidosis with suspected cardiac involvement was
made. Bronchoscopy with transbronchial lung biopsy
was not attempted because systemic sarcoidosis had
already been confirmed with skin biopsies and further
intervention in an unstable patient was considered
unnecessary.
Holter monitoring showed recurrent episodes of
sustained monomorphic VT. Her coronary angiogram was
normal. Her echocardiography revealed a left ventricular
ejection fraction (EF) of 48% with hypokinesia of the
mid-basal interventricular septum (IVS). Cardiac magnetic
resonance imaging (MRI) with gadolinium contrast
showed evidence of late enhancement in both the apical
and anteroseptal left ventricular regions suspicious for
fibrosis (Figure 5). To further confirm the diagnosis of
cardiac involvement, endomyocardial biopsies were per-
formed. However, her endomyocardial biopsies did not
reveal granulomas, but showed focal interstitial fibrosis
(Figure 6a, 6b).
On the basis of the above clinical and investigational
findings, diagnosis of systemic sarcoidosis with cardiac in-
volvement was made. She satisfied the Japanese Ministry
of Health and Welfare guidelines for diagnosis of cardiacardia.
Figure 4 Skin biopsy showing non-caseating discrete granuloma (arrow) (×200, hematoxylin and eosin stain).
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cardiac sarcoidosis) [5]. She was started on prednisolone
at a dose of 1mg/kg/day in addition to supportive care.
She received multiple antiarrhythmic drugs including oral
amiodarone at a maintenance dose of 300mg daily and
metoprolol at a dose of 100mg twice daily without any sat-
isfactory response. Radiofrequency ablation was attempted
twice but failed to suppress the ventricular arrhythmia.
She was then planned for automatic implantable cardiac
defibrillator (AICD) implantation which could not be
done due to financial constraints. In the following week,Figure 5 Cardiac magnetic resonance imaging (contrast
enhanced) showing enhancement of anteroseptal left
ventricular region (long arrow).the patient died following an episode of VT that was unre-
sponsive to defibrillation. The patient’s family refused aut-
opsy studies.
Guidelines for the diagnosis of cardiac sarcoidosis [5]
Histological diagnosis group
Cardiac sarcoidosis is confirmed when endomyocardial
biopsy specimens demonstrate non-caseating epithelioid
cell granulomas with histological or clinical diagnosis of
extracardiac sarcoidosis.
Clinical diagnosis group
If endomyocardial biopsy specimens do not demonstrate
non-caseating epithelioid granulomas, then extracardiac
sarcoidosis is diagnosed histologically or clinically when
the following combination of major or minor diagnostic
criteria are satisfied:
1. Two or more of the four major criteria are satisfied
2. One in four of the major criteria and two or more of
the five minor criteria are satisfied
Major criteria
1. Advanced atrioventricular block
2. Basal thinning of the interventricular septum
3. Positive gallium-67 uptake in the heart
4. Depressed ejection fraction of the left ventricle (<50%)
Minor criteria
1. Abnormal electrocardiogram findings: ventricular
arrhythmias (ventricular tachycardia, multifocal or
frequent premature ventricular contractions ),
ab
Figure 6 Endomyocardial biopsies showing mild interstitial fibrosis (arrows). a: ×100, hematoxylin and eosin stain. b: ×40, Masson
trichrome stain.
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or abnormal Q wave
2. Abnormal echocardiography: regional abnormal wall
motion or morphological abnormality (ventricular
aneurysm, wall thickening)
3. Nuclear medicine: perfusion defect detected by
thallium-201 or technetium-99m myocardial
scintigraphy
4. Gadolinium-enhanced contrast magnetic resonance
imaging: delayed enhancement of myocardium
5. Endomyocardial biopsy: interstitial fibrosis or
monocyte infiltration of moderate grade
Discussion
Sarcoidosis is a multisystem granulomatous disease, which
predominantly affects 20- to 30-year olds of both sexes.
Most patients present with pulmonary involvement. Inaddition to the lungs, other affected organs are, in de-
creasing order of frequency, skin, liver, gastrointestinal
tract, eyes and nervous system [6]. Cardiac involvement is
one of the least common manifestations. In a recent re-
view, the incidence of clinical heart involvement was
reported as approximately 5%, whereas at autopsy the in-
cidence was considerably higher (20 to 25%) [6-8].
The course of sarcoidosis can be indolent; however,
acute complications in cardiac sarcoidosis can lead to sud-
den cardiac death [9,10]. Non-caseating granulomas serve
as foci for abnormal automaticity and cause changes in
the ventricular activation and recovery process, which ex-
plains the reentry mechanism that is thought to lead to
VT in cardiac sarcoidosis [11].
Ante mortem diagnosis of cardiac sarcoidosis is difficult
because of its wide-ranging clinical manifestations and the
limitations of available diagnostic tests. Guidelines for the
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the Japanese Ministry of Health and Welfare although
they have not been validated (see section Guidelines for
the diagnosis of cardiac sarcoidosis) [5,12]. Although
possible cases of cardiac sarcoidosis should initially have
an echocardiogram to look for supportive findings such as
regional wall motion abnormalities, thickening of IVS with
bright shadow consistent with infiltration and impaired
left ventricular EF, these findings are not specific. Cardiac
MRI with gadolinium enhancement and PET scanning are
valuable aids in the diagnosis of myocardial sarcoidosis and
are considered superior to gallium-labeled or technetium-
labeled nuclear scans [13,14]. Reports suggest that the sen-
sitivity of detecting sarcoid granuloma on endomyocardial
biopsy is around 20%; hence a negative biopsy does not ex-
clude the disease [15].
Sarcoidosis that involves the heart warrants prompt
treatment with corticosteroids with or without other im-
munosuppressive agents [16]. A recent study showed
that corticosteroids are more helpful in patients with
mild to moderate left ventricular function impairment
(left ventricular EF of 30 to 50%), whereas those with a
severely reduced left ventricular EF of less than 30% in
the late stage of disease did not benefit (probably be-
cause of irreversible myocardial damage and fibrosis)
[17]. This is in keeping with our case where the patient
presented in the late stages and did not show a response
to steroids.
Ventricular arrhythmias are common in cardiac sar-
coidosis but are often refractory to antiarrhythmic drugs
including amiodarone. Most authorities recommend
placement of an electronic pacemaker for complete
heart block and an automatic implantable cardioverter-
defibrillator for ventricular fibrillation or tachycardia
and markedly reduced left ventricular EF [18]. Cardiac
transplantation is a useful option in cardiac sarcoidosis
refractory to medical management, however, some stud-
ies have shown a trend towards increased mortality
[19,20]. However, with progress in prevention and treat-
ment of ventricular arrhythmias, the primary cause of
death in cardiac sarcoidosis has changed from sudden
death to congestive heart failure.
Conclusions
Cardiac involvement should be ruled out in any patients
with systemic sarcoidosis. A negative endomyocardial bi-
opsy should not be taken as evidence of the absence of
cardiac sarcoidosis, particularly if suspicion is strong.
Advances in cardiac imaging seem to be improving the
diagnosis and, when highly suggestive, should prompt a
search for a positive tissue biopsy in a visualized abnor-
mal area of the myocardium or from a non-cardiac site.
Steroid therapy seems to be beneficial when used rela-
tively early in the course of the disease. Due to the riskof arrhythmia in this disease, a strong consideration for
prophylactic implantation of an AICD should be consid-
ered, particularly in the presence of ventricular arrhyth-
mias or reduced EF.
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